Growth Metrics

Insulet (PODD) Receivables - Other (2017 - 2023)

Insulet filings provide 7 years of Receivables - Other readings, the most recent being $57.6 million for Q1 2023.

  • On a quarterly basis, Receivables - Other rose 60.89% to $57.6 million in Q1 2023 year-over-year; TTM through Mar 2023 was $57.6 million, a 60.89% increase, with the full-year FY2022 number at $64.7 million, up 150.78% from a year prior.
  • Receivables - Other hit $57.6 million in Q1 2023 for Insulet, down from $64.7 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $64.7 million in Q4 2022 to a low of $9.5 million in Q1 2019.
  • Median Receivables - Other over the past 5 years was $17.3 million (2021), compared with a mean of $27.0 million.
  • Biggest five-year swings in Receivables - Other: dropped 19.28% in 2021 and later skyrocketed 200.0% in 2022.
  • Insulet's Receivables - Other stood at $13.5 million in 2019, then fell by 14.07% to $11.6 million in 2020, then skyrocketed by 122.41% to $25.8 million in 2021, then skyrocketed by 150.78% to $64.7 million in 2022, then dropped by 10.97% to $57.6 million in 2023.
  • The last three reported values for Receivables - Other were $57.6 million (Q1 2023), $64.7 million (Q4 2022), and $48.3 million (Q3 2022) per Business Quant data.